Avanos Medical (AVNS) Non-Current Debt (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Non-Current Debt data on file, last reported at $87.3 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 10.92% year-over-year to $87.3 million; the trailing twelve-month figure through Mar 2026 stood at $87.3 million (down 10.92% YoY), and the FY2025 full-year result was $90.3 million, down 27.93% from the prior year.
• Non-Current Debt retreated to $87.3 million in Q1 2026, from $90.3 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $258.3 million in Q3 2023 to a low of $87.3 million in Q1 2026.
• A 5-year average of $169.3 million and a median of $164.9 million in 2024 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt soared 74.08% in 2022 and plunged 41.96% in 2025, its largest moves.
• Tracing AVNS's Non-Current Debt over 5 years: stood at $226.3 million in 2022, then decreased by 29.56% to $159.4 million in 2023, then dropped by 21.39% to $125.3 million in 2024, then retreated by 27.93% to $90.3 million in 2025, then decreased by 3.32% to $87.3 million in 2026.
• Business Quant data shows AVNS's Non-Current Debt at $87.3 million in Q1 2026, $90.3 million in Q4 2025, and $93.4 million in Q3 2025.